Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;193(2):293-303.
doi: 10.1007/s10549-022-06549-9. Epub 2022 Mar 13.

Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty

Affiliations

Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty

Jet W Ankersmid et al. Breast Cancer Res Treat. 2022 Jun.

Abstract

Purpose: For the implementation of personalised surveillance, it is important to create more awareness among HCPs with regard to the risk for locoregional recurrences (LRRs). The aim of this study is to evaluate the current awareness and estimations of individual risks for LRRs after completion of primary treatment for breast cancer among health care professionals (HCPs) in the Netherlands, without using any prediction tools.

Methods: A cross-sectional survey was performed among 60 HCPs working in breast cancer care in seven Dutch hospitals and 25 general practitioners (GPs). The survey consisted of eleven realistic surgically treated breast cancer cases. HCPs were asked to estimate the 5-year risk for LRRs for each case, which was compared to the estimations by the INFLUENCE-nomogram using one-sample Wilcoxon tests. Differences in estimations between HCPs with different specialities were determined using Kruskal-Wallis tests and Dunn tests.

Results: HCPs tended to structurally overestimate the 5-year risk for LRR on each case. Average overestimations ranged from 4.8 to 26.1%. Groups of HCPs with varying specialities differed significantly in risk estimations. GPs tended to overestimate the risk for LRRs on average the most (15.0%) and medical oncologists had the lowest average overestimation (2.7%).

Conclusions: It is important to create more awareness of the risk for LRRs, which is a pre-requisite for the implementation of personalised surveillance after breast cancer. Besides education for HCPs, the use of prediction models such as the INFLUENCE-nomogram can support in estimating an objective estimate of each individual patient's risk.

Keywords: Breast cancer; Health care providers; Recurrence; Risk; Surveillance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Estimated 5-year risks for locoregional recurrences on all cases
Fig. 2
Fig. 2
Average overestimations for all cases per specialty

References

    1. Integraal Kankercentrum Nederland (IKNL). NKR cijfers [NCR numbers]. https://iknl.nl/nkr-cijfers?fs%7Cepidemiologie_id=526&fs%7Ctumor_id=1&fs...
    1. NABON (2012). Breast cancer - Dutch Guideline, version 2.0. Oncoline. https://www.oncoline.nl/uploaded/docs/mammacarcinoom/Dutch%20Breast%20Ca...
    1. Geurts SME, de Vegt F, Siesling S, et al. Pattern of follow-up care and early relapse detection in breast cancer patients. Breast Cancer Res Treat. 2012;136:859–868. doi: 10.1007/s10549-012-2297-9. - DOI - PubMed
    1. Geurts YM, Witteveen A, Bretveld R, et al. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Res Treat. 2017;165:709–720. doi: 10.1007/s10549-017-4340-3. - DOI - PMC - PubMed
    1. Witteveen A, Vliegen IM, Sonke GS, et al. Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients. Breast Cancer Res Treat. 2015;152(3):627–636. doi: 10.1007/s10549-015-3490-4. - DOI - PMC - PubMed